TrialMedical oncology (Northwood, London, England)2015

A phase II open-label clinical study of comparing nab-paclitaxel with pemetrexed as second-line chemotherapy for patients with stage IIIB/IV non-small-cell lung cancer.

Zhefeng Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.